Growth stocks have lost momentum in August after a strong start to the year. The market is worried about the impact of a possible recession, high inflation, and high interest rates on the future earnings of companies. However, smart investors know that market downturns can create attractive buying opportunities.

Healthcare stocks have been especially hit hard this month. Innovative companies in the fields of drug development and medical imaging, such as Agenus (NASDAQ: AGEN), BioCryst Pharmaceuticals (NASDAQ: BCRX), and Nano-X Imaging (NASDAQ: NNOX) have all experienced a significant drop in their stock prices in the past 30 days. Here's why these three beaten-down growth stocks may be worth buying on the dip.

Continue reading

Source Fool.com